Track BNB Plus Corp. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

BNB Plus Corp. BNBX Open BNB Plus Corp. in new tab

0.6527 USD
P/E
0.00
EPS
282.39
P/B
0.17
ROE
-199.14
Beta
0.69
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E0.00
EPS282.39
Book Value3.95
Price to Book0.17
Debt/Equity0.27
% Insiders11.470%
Growth
Revenue Growth-0.35%

DCF Valuation

Tweak assumptions to recompute fair value for BNB Plus Corp. (BNBX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

BNB Plus Corp. Logo BNB Plus Corp. Analysis (BNBX)

US Healthcare Official Website Stock

Is BNB Plus Corp. a good investment? BNB Plus Corp. (BNBX) is currently trading at 0.6527 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.00. This relatively low multiple may signal that BNB Plus Corp. is undervalued compared to historical market norms.

Earnings Schedule: BNB Plus Corp. is expected to release its next earnings report on Aug. 6, 2026.

Investor FAQ

Does BNB Plus Corp. pay a dividend?

No, it does not currently pay a dividend.

What asset class is BNB Plus Corp.?

BNB Plus Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 282.39.

Company Profile

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.

Exchange Ticker
NASDAQ BNBX

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
June 2, 2025 0.070000
June 2, 2025 0.070000
Oct. 29, 2014 0.016667
Nov. 1, 2019 0.025000
April 25, 2024 0.050000
March 14, 2025 0.020000
June 2, 2025 0.066667
June 2, 2025 0.070000
Nov. 1, 2019 0.030000
Oct. 29, 2014 0.020000
June 2, 2025 0.070000
June 2, 2025 0.070000
June 2, 2025 0.070000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion